• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Novartis

Tilak inks distro deal with Novartis for vision app

December 8, 2020 By Sean Whooley

Tilak Healthcare announced today that it entered into a framework agreement with Novartis (NYSE:NVS) to promote its OdySight remote monitoring app. Paris-based Tilak’s OdySight is a smartphone application designed to monitor and engage patients with age-related chronic eye diseases. The app is available by prescription and includes vision tests and puzzles to boost engagement while strengthening the patient-client […]

Filed Under: Business/Financial News, Optical/Ophthalmic, Patient Monitoring Tagged With: Novartis, Tilak Healthcare

Siemens, Novartis team up on MS drug development

September 21, 2020 By Nancy Crotti

Siemens Healthineers (ETR:SHL)  and Novartis (NYSE:NVS) have agreed to jointly design, develop and commercialize diagnostic tests for therapeutic products across Novartis’ therapeutic pipeline, the companies announced today. The first project will be a serum neurofilament light chain (NfL) immunoassay for patients with multiple sclerosis (MS) and other neurological diseases. Get the full story on our sister site, Drug […]

Filed Under: Business/Financial News, Distribution, Featured, Neurological, Pharmaceutical, Research & Development Tagged With: Novartis, Siemens Healthineers

Cala cites positive data in Trio tremor trial

August 17, 2020 By Tom Salemi

Bioelectronic company Cala Health released positive data from its ongoing PROSPECT trial demonstrating that a majority of patients using its  FDA-cleared Cala Trio device reported a reduction in hand tremors. The study — published in Tremor and Other Hyperkinetic Movements — enrolled 263 patients with essential tremor across 26 sites. Patients wore the Trio on […]

Filed Under: Bioelectronic Medicine, Clinical Trials, Featured Tagged With: Abbott, Cala Health, Intuitive Surgical, Novartis

The most innovative pharmaceutical agents of 2020

August 3, 2020 By Danielle Kirsh

The Galien Foundation recently announced nominees for most innovative pharmaceutical agents for its 14th Annual Prix Galien USA Awards. The foundation bestows the Prix Galien Award annually to examples of outstanding biomedical, pharmaceutical drugs and medical technology products that are designed to improve the human condition. “As we celebrate 50 years of the Prix Galien process, […]

Filed Under: Cardiovascular, Featured, Neurological, Oncology, Pharmaceutical Tagged With: AbbVie, Adlon Therapeutics, Advanced Accelerator Applications, Astellas Pharma, Bayer, Eli Lilly & Co., Galien Foundation, Genentech, Greenwich Biosciences, GW Pharmaceuticals, Janssen Biotech, Johnson & Johnson, Karyopharm Therapeutics, Medicines Development for Global Health, Merck, Novartis, Pfizer, Population Council, Purdue Pharma, Roche Group, Servier Pharmaceuticals, SIGA Technologies, Sobi, TB Alliance, Theravance Biopharma

MedTech 100 roundup: Stocks tick back up to open July

July 6, 2020 By Sean Whooley

After a solid start to July, the medtech industry continues to experience a stock market roller coaster amid the COVID-19 pandemic. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 84.25 points at the end of last week (July 3). That total represents a 2.9% increase from […]

Filed Under: Business/Financial News, Featured, Legal News, MassDevice Earnings Roundup, Mergers & Acquisitions, Research & Development, Wall Street Beat Tagged With: Abbott, alexionpharmaceuticals, coronavirus, COVID-19, DeviceTalks, DeviceTalks Weekly, MedTech 100 Index, Novartis, RTI Surgical, Smith & Nephew, Stryker, tandemdiabetes, Wright Medical

Novartis, Alexion charged with FPCA violations

July 2, 2020 By Sean Whooley

Novartis (NYSE:NVS) and Alexion Pharmaceuticals (NSDQ:ALXN) were charged with violations of the books and records and internal accounting controls provisions of the Foreign Corrupt Practices Act (FCPA). The Securities & Exchange Commission (SEC) announced that the pharmaceutical companies both committed violations and both agreed to pay millions of dollars to settle the charges. Novartis settled to pay over […]

Filed Under: Business/Financial News, Legal News, Pharmaceutical Tagged With: Alcon, alexionpharmaceuticals, Novartis, Securities & Exchange Commission (SEC)

FDA clears Verily Study Watch for additional capabilities

January 22, 2020 By Chris Newmarker

Verily, Google’s life science’s sister company under Alphabet (NSDQ:GOOGL), has received an FDA 510(k) clearance to include an irregular pulse monitor in its Study Watch wearable. The FDA announcement, last updated Jan. 20, did not include additional information. The agency cleared ECG capabilities on the Study Watch in January 2019. Launched in April 2017, the Study […]

Filed Under: 510(k), Clinical Trials, Digital Health, Featured, Food & Drug Administration (FDA), Patient Monitoring, Pharmaceutical, Regulatory/Compliance Tagged With: Alphabet (Google), Novartis, Otsuka Holdings, Pfizer, Sanofi, Verily

Novartis unit spikes Pear Therapeutics deal

October 17, 2019 By Sean Whooley

Novartis (NYSE:NVS) unit Sandoz said this week that Pear Therapeutics will take sole responsibility for the commercialization of their prescription digital therapeutics program for treating substance and opioid use disorders. In April 2018, Pear announced that it agreed to deal commercialization rights of its digital therapeutics to Sandoz. The companies did not disclose financial details, but […]

Filed Under: Business/Financial News, Pharmaceutical Tagged With: Novartis, Pear Therapeutics, sandoz

Freshly spun-out Alcon posts Q1 sales beat

May 16, 2019 By Fink Densford

Shares in Alcon (NYSE:ALC) are steady today after the ophthalmic device maker, freshly spun out from Novartis (NYSE:NVS), posted first quarter 2019 earnings that beat sales expectations on Wall street. The Geneva-based company posted sales of $1.8 billion for the three months ended March 31, just in line with its sales during the same quarter of […]

Filed Under: Business/Financial News, MassDevice Earnings Roundup, Wall Street Beat Tagged With: Alcon, Novartis

Smiths Medical, United Therapeutics conspired to stifle generic Remodulin, Sandoz alleges

April 19, 2019 By Brad Perriello

Smiths Medical allegedly conspired with United Therapeutics to stifle a generic version of pulmonary arterial hypertension drug Remodulin, according to a lawsuit filed this week by Novartis (NYSE:NVS) unit Sandoz. The  Smiths Group (LON:SMIN) subsidiary, which is slated for a spinout as a separately traded company next year, makes the infusion pumps and single-use cartridges for the PAH drug treprostinil, sold […]

Filed Under: Drug Pumps, Drug-Device Combinations, Featured, Legal News Tagged With: Novartis, sandoz, Smiths Group plc, Smiths Medical, United Therapeutics

Medtronic taps Lennon as CIO | Personnel Moves – April 9, 2018

April 9, 2019 By Fink Densford

Medtronic (NYSE:MDT) said that it named Sean Lennon as its new chief information officer, set to take effect April 29. The Fridley, Minn.-based medtech giant said that Lennon will take over for Mike Hedges, who is retiring from the position after 19 years with Medtronic, including 10 as CIO. Prior to joining Medtronic, Lennon served as […]

Filed Under: Business/Financial News, Wall Street Beat Tagged With: Allergan, Clearside Biomedical, ICU Medical Inc., iHear Medical, LifeScan Inc., lumenxt, Medtronic, Novartis, OptiScan, oregonbioscienceassociation, Owens and Minor, Shape Memory Therapeutics, SynCardia

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 11
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS